Mutual Fund Details

LIC MF Healthcare Fund Direct - Growth

Equity Pharma

NAV

₹25.6234

as on 16 Apr 2024, 11:15 PM

₹0.0653(0.26%)

Last Change

Schemes Managed By

Karan Doshi

Investment Performance

would have given a return of

₹1,10,871

₹1,21,647

₹1,38,205

₹1,43,388

Bank Account

Fixed Deposit

Regular Mutual Fund

This Fund on Paytm Money

This Mutual Fund

₹43,388

Profit (absolute return)

43.39%

in the last

max

+1% Higher Returns

With Direct Plans on Paytm Money

Investment Returns

In the last 3 months

9.58%

In the last 6 months

26.18%

In the last 1 year

45.73%

In the last 3 years

43.39%

In the last 5 years

152.45%

In the last 10 years

Absolute Returns

CAGR

Scheme Riskometer

low

low to moderate

moderate

moderately high

high

very high

Investors understand that their principal will be at very high risk

Scheme Information

LIC MF Healthcare Fund Direct - Growth

as of 31 Mar 2024, 05:30 AM

₹61.69 Cr

Scheme Asset Size

Fund Type

Open-End

Exit Load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

1.21%

Expense Ratio

Plan

Growth

3.91%

Cash Holding

Benchmark

S&P BSE Healthcare Total Return Index

Scheme Document

View

Benchmark

S&P BSE Healthcare Total Return Index

Exit Load

Exit Load for units in excess of 12% of the investment,1% will be charged for redemption within 90 days.

Scheme Document

View

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

94.98%

₹58.59 Cr

Others

5.02%

₹3.10 Cr

Sectors Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Sector

Healthcare

94.98%

₹58.59 Cr

Others

5.02%

₹3.10 Cr

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.88%

₹9.18 Cr

Zydus Lifesciences Ltd.

7.46%

₹4.60 Cr

JB Chemicals & Pharmaceuticals Ltd.

6.27%

₹3.87 Cr

Piramal Pharma Ltd.

5.78%

₹3.57 Cr

Cipla Ltd.

5.71%

₹3.52 Cr

Others

59.90%

₹36.95 Cr

View All

Companies Holding in this Mutual Fund

as on 31 Mar 2024

Sort By

Value

Company

Sun Pharmaceutical Industries Ltd.

14.88%

₹9.18 Cr

Zydus Lifesciences Ltd.

7.46%

₹4.60 Cr

JB Chemicals & Pharmaceuticals Ltd.

6.27%

₹3.87 Cr

Piramal Pharma Ltd.

5.78%

₹3.57 Cr

Cipla Ltd.

5.71%

₹3.52 Cr

Others

59.90%

₹36.95 Cr

View All

Funds in this Category

This fund's returns:

12.75%

Return Duration

3 Years

SBI Healthcare Opportunities Fund Direct Plan-Growth

ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth

Tata India Pharma & HealthCare Fund Direct-Growth

About LIC MF Healthcare Fund Direct - Growth

LIC MF Healthcare Fund Direct - Growth is a Equity mutual fund scheme from LIC Mutual Fund. This scheme was launched on Invalid date and is currently managed by its fund manager Karan Doshi. It has an AUM of ₹61.69 Crores and the latest NAV decalared is ₹25.623 as on 18 Apr 2024 at 5:42 pm.

LIC MF Healthcare Fund Direct - Growth scheme return performance in last 1 year is 45.73%, in last 3 years is 43.39% and 155.72% since scheme launch. The min. SIP amount to invest in this scheme is ₹1000.